tiprankstipranks
Takeda Pharmaceutical Raises FY2024 Financial Forecast
PremiumCompany AnnouncementsTakeda Pharmaceutical Raises FY2024 Financial Forecast
22d ago
Spyre Therapeutics price target raised to $65 from $50 at Guggenheim
Premium
The Fly
Spyre Therapeutics price target raised to $65 from $50 at Guggenheim
28d ago
Takeda and BMC team on decarbonization across health care ecosystem
Premium
The Fly
Takeda and BMC team on decarbonization across health care ecosystem
29d ago
Takeda receives European Commission approval for ADZYNMA
PremiumThe FlyTakeda receives European Commission approval for ADZYNMA
4M ago
Protagonist Therapeutics price target lowered to $43 from $45 at JMP Securities
Premium
The Fly
Protagonist Therapeutics price target lowered to $43 from $45 at JMP Securities
4M ago
Takeda Pharmaceutical Sees Strong Quarterly Growth
Premium
Company Announcements
Takeda Pharmaceutical Sees Strong Quarterly Growth
4M ago
Takeda Reinforces Governance with New Director Roles
PremiumCompany AnnouncementsTakeda Reinforces Governance with New Director Roles
5M ago
Takeda: Japanese MHLW approves LIVTENCITY
Premium
The Fly
Takeda: Japanese MHLW approves LIVTENCITY
5M ago
Takeda receives approval from European Commission for FRUZAQLA
Premium
The Fly
Takeda receives approval from European Commission for FRUZAQLA
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100